Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Ivermectin
Norbrook Laboratories Limited
QP54AA01
Ivermectin
0.5 percent weight/volume
Pour-on solution
LM: Licensed Merchant as defined in relevant national legislation
Cattle
ivermectin
Endoparasiticide
Authorised
2000-03-13
Health Products Regulatory Authority 15 January 2018 CRN000WPZ Page 1 of 6 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Noromectin 0.5% w/v Pour-On Solution for Cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Active substance_ Ivermectin 0.5% w/v _Excipients: _ Patent Blue V (E131) dye 0.0005% w/v Isopropyl alcohol to 100.0% v/v For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Pour-on solution A clear, blue solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (beef and non-lactating cattle). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Noromectin Pour-On is indicated for the effective treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, eyeworms, warbles, mites and lice. GASTROINTESTINAL ROUNDWORMS (ADULTS AND FOURTH STAGE LARVAE): _Ostertagia ostertagi _(including inhibited _O ostertagi_), _Haemonchus placei, _ _Trichostrongylus axei, Trichostrongylus colubriformis, Cooperia _spp, _Oesophagostomum radiatum, Strongyloides papillosus _(adult)_, Trichuris _spp (adult). Occasionally variable activity may be observed against _H. placei_ (L4), _Cooperia_ spp, _T. _ _axei_ and _T. colubriformis_. LUNGWORMS (ADULT AND FOURTH STAGE LARVAE): _Dictyocaulus viviparus_ EYEWORMS (ADULT): _Thelazia rhodesii_ Health Products Regulatory Authority 15 January 2018 CRN000WPZ Page 2 of 6 WARBLES (PARASITIC STAGES): _Hypoderma bovis, Hypoderma lineatum_ SUCKING LICE: _Linognathus vituli, Haematopinus eurysternus,_ BITING LICE: _Damalinia (bovicola) bovis_ MANGE MITES: _Chorioptes bovis, Sarcoptes scabiei _var _bovis_ 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy. - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing which may be due to unde Prečítajte si celý dokument